Study News & Data
Multiple Sclerosis One-Month Results
2/19/2019
Press release announcing initial MS one-month results.
Full lab and questionnaire data will be posted soon
-
yFFP recipients saw improvements in 37/55 categories
-
Critical disease-related conditions such as fatigue, mobility, concentration and urinary control saw dramatic improvements
Assessment Results
Lab Results
Lab Analyses
About the Plasma from Young Donors Study
The yFFP Treatment for Parkinson's Disease & MS Study is the first of its kind
-
Kicked off in November of 2018
-
Occurring in Houston's Texas Medical Center
-
Study is double-blind and randomized
-
20 Parkinson's Disease participants
-
20 Multiple Sclerosis participants
-
Non-placebo participants will receive 25mg/kg of yFFP
-
Initial results released at A4M World Convention in December 2018 in Las Vegas, NV
-
All one-month assessment data will be released in February, 2019
-
Three-month and six-month assessment data will be released in April and July, 2019
Study Protocol
NuPlasma Quality Brochure
Plasma Facts
BEGINNINGS
Plasma was first used in the 1920's as a life-saving medicine following World War I
TODAY
Today, over 10,000 units of FFP are used every day in the United States. Because of these high volumes, FFP's safety is well-documented
yFFP Revolution
In the 1950s a young mouse and an older mouse were sutured together in what's called "Parabiosis". The older mouse improved in both cognitive and physical measurements
Plasma from "young" donors
Plasma from "Young" Donors is best defined as FFP collected from a donor between the ages 18-25
Meet The Team
Dr. Dian Ginsberg
Obstetrics, Gynecology & Anti-Aging
Dr. Igor Cherches
Neurologist
Dr. Eddie Patton
Neurologist
